Supporting Orphan Drug Aseptic Fill Finish Rare diseases, also known as orphan diseases, are a group of diverse and often life-threatening conditions that collectively affect a small percentage of the
Why Your Biotech Contract Manufacturer is Expanding in Combination Product and Drug-Fill/Finish in 2024 Letter to Our Colleagues, from Founder/CEO Wayne Woodard, Argonaut Manufacturing Services As 2024 gets underway, I’d
KBI Biopharma, Inc. and Argonaut Manufacturing Services, Inc. Forge Strategic Alliance to Support Global Biopharmaceutical Companies with Integrated Drug Substance and Drug Product Solutions Alliance combines strengths of both companies
The biotech diagnostic manufacturing and development industry is undergoing rapid transformation driven by innovations that enhance sustainability and improve access to accurate diagnoses while optimizing resources. In a recent discussion between
In recent years, the field of biotechnology has experienced significant progress, particularly in diagnostic manufacturing. Biotech diagnostic manufacturing ecosystems have evolved into dynamic networks comprising research institutions, biotech companies, regulatory
As we wrap up 2023 and look ahead to 2024, the biotech industry reflects on a challenging year behind us marked by the aftermath of the pandemic and extremely challenging
Argonaut Receives Excellence in North County Economic Development Award On December 14th, 2023, Argonaut was recognized by the San Diego North Economic Development Council for its growth and continued investment
… but things may be looking up. Marketplace Podcast, Interview With CEO Wayne Woodard Public media podcast, Marketplace, delves into the intricate responses of manufacturing companies to the challenges posed
In this n-Lorem podcast episode, Bottling Hope, host Stan Crook introduces guest Wayne Woodard, CEO of Argonaut. Wayne details his background in industrial technology, emphasizing the importance of operational roles
Argonaut Manufacturing Services in a Molecule to Market Podcast Episode In the podcast series Molecule to Market, Raman Sehgal interviews influential leaders in the biopharmaceutical industry. In this recent episode, he